Greg Behar, Recipharm CEO
March 14, 2025 01:07 PM EDT
Pharma
Manufacturing

Re­ci­pharm hits record rev­enue for 2024, eyes GLP-1 con­tracts for growth 

Anna Brown

News Reporter

Greg Be­har’s shake­up of Re­ci­pharm is pay­ing off in his first year as CEO.

The CD­MO re­port­ed record-high rev­enues on Fri­day, and the com­pa­ny ex­pects …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

RFK Jr. con­vened round­table around ways to re­duce stem cell reg­u­la­tion

Sutro slash­es work­force in half, changes CEO and clos­es fac­to­ry

Boston Phar­ma, build­ing off MASH mo­men­tum, mulls an IPO ahead of Phase 3 tri­al

Pfiz­er ter­mi­nates an ear­ly-stage STING ag­o­nist tri­al

Lil­ly-part­nered Fau­na Bio plans $40M Se­ries A to get in­to heart fail­ure

sponsored

Obe­si­ty drug de­vel­op­ment—still room to grow

A service from the Financial Times